CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
CytomX Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 27, 2023
CytomX Therapeutics reported fiscal year 2021 executive compensation information on April 27, 2023.
In 2021, six executives at CytomX Therapeutics received on average a compensation package of $2.1M, a 32% increase compared to previous year.
Average pay of disclosed executives at CytomX Therapeutics
Sean A. McCarthy, Chief Executive Officer, received $4.3M in total, which increased by 52% compared to 2020. 68% of McCarthy's compensation, or $2.9M, was in option awards. McCarthy also received $360K in non-equity incentive plan, $616K in salary, $427K in stock awards, as well as $5K in other compensation.
Amy Peterson, Chief Operating Officer, received a compensation package of $2.3M, which increased by 150% compared to previous year. 55% of the compensation package, or $1.2M, was in option awards.
Jeff Landau, Senior Vice President and Chief Business Officer, earned $1.8M in 2021.
Alison Hannah, Chief Medical Officer, received $1.7M in 2021, which increases by 2% compared to 2020.
Lloyd A. Rowland, General Counsel, earned $1.4M in 2021, a 49% increase compared to previous year.
Carlos Campoy, Chief Financial Officer, received $1.4M in 2021, which decreases by 20% compared to 2020.
Related executives
Jeff Landau
CytomX Therapeutics
Senior Vice President and Chief Business Officer
Sean McCarthy
CytomX Therapeutics
Chief Executive Officer
Amy Peterson
CytomX Therapeutics
Chief Operating Officer
Carlos Campoy
CytomX Therapeutics
Chief Financial Officer
Lloyd Rowland
CytomX Therapeutics
Senior Vice President,
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
You may also like
Source: SEC filing on April 27, 2023.